Approaches towards expression profiling the response to treatment

por Sims, Andrew H, Bartlett, John MS
Publicado 2008

HER4 in breast cancer: comparison of antibodies against intra- and extra-cellular domains of HER4

por Tovey, Sian M, Dunne, Barbara, Witton, Caroline J, Cooke, Timothy G, Bartlett, John MS
Publicado 2006

Breast cancer biomarkers in clinical testing: analysis of a UK national external quality assessment scheme for immunocytochemistry and in situ hybridisation database containing res...

por Dodson, Andrew, Parry, Suzanne, Ibrahim, Merdol, Bartlett, John MS, Pinder, Sarah, Dowsett, Mitch, Miller, Keith
Publicado en J Pathol Clin Res (2018)

Relative impact of key sources of systematic noise in Affymetrix and Illumina gene-expression microarray experiments

por Kitchen, Robert R, Sabine, Vicky S, Simen, Arthur A, Dixon, J Michael, Bartlett, John MS, Sims, Andrew H
Publicado 2011

Outcome and human epidermal growth factor receptor (HER) 1–4 status in invasive breast carcinomas with proliferation indices evaluated by bromodeoxyuridine labelling

por Tovey, Sian M, Witton, Caroline J, Bartlett, John MS, Stanton, Peter D, Reeves, Jonathan R, Cooke, Timothy G
Publicado 2004

Is TIMP-1 immunoreactivity alone or in combination with other markers a predictor of benefit from anthracyclines in the BR9601 adjuvant breast cancer chemotherapy trial?

por Munro, Alison F, Bartels, Annette, Balslev, Eva, Twelves, Christopher J, Cameron, David A, Brünner, Nils, Bartlett, John MS
Publicado 2013

Correcting for intra-experiment variation in Illumina BeadChip data is necessary to generate robust gene-expression profiles

por Kitchen, Robert R, Sabine, Vicky S, Sims, Andrew H, Macaskill, E Jane, Renshaw, Lorna, Thomas, Jeremy S, van Hemert, Jano I, Dixon, J Michael, Bartlett, John MS
Publicado 2010

A four gene signature predicts benefit from anthracyclines: evidence from the BR9601 and MA.5 clinical trials

por Spears, Melanie, Yousif, Fouad, Lyttle, Nicola, Boutros, Paul C., Munro, Alison F., Twelves, Chris, Pritchard, Kathleen I., Levine, Mark N., Shepherd, Lois, Bartlett, John MS.
Publicado en Oncotarget (2015)

Molecular characterisation of isogenic taxane resistant cell lines identify novel drivers of drug resistance

por Kenicer, Juliet, Spears, Melanie, Lyttle, Nicola, Taylor, Karen J, Liao, Linda, Cunningham, Carrie A, Lambros, Maryou, MacKay, Alan, Yao, Cindy, Reis-Filho, Jorge, Bartlett, John MS
Publicado 2014

A four gene signature of chromosome instability (CIN4) predicts for benefit from taxanes in the NCIC-CTG MA21 clinical trial

por Spears, Melanie, Lyttle, Nicola, D'Costa, Alister, Chen, Bingshu E., Yao, Cindy Q., Boutros, Paul C., Burnell, Margot, Levine, Mark N., O'Brien, Patti, Shepherd, Lois, Bartlett, John M.S.
Publicado en Oncotarget (2016)

Response to mTOR inhibition: activity of eIF4E predicts sensitivity in cell lines and acquired changes in eIF4E regulation in breast cancer

por Satheesha, Sampoorna, Cookson, Victoria J, Coleman, Louise J, Ingram, Nicola, Madhok, Brijesh, Hanby, Andrew M, Suleman, Charlotte AB, Sabine, Vicky S, Macaskill, E Jane, Bartlett, John MS, Dixon, J Michael, McElwaine, Jim N, Hughes, Thomas A
Publicado 2011

Multidisciplinary Meeting on Male Breast Cancer: Summary and Research Recommendations

por Korde, Larissa A., Zujewski, Jo Anne, Kamin, Leah, Giordano, Sharon, Domchek, Susan, Anderson, William F., Bartlett, John M.S., Gelmon, Karen, Nahleh, Zeina, Bergh, Jonas, Cutuli, Bruno, Pruneri, Giancarlo, McCaskill-Stevens, Worta, Gralow, Julie, Hortobagyi, Gabriel, Cardoso, Fatima
Publicado 2010

Mammostrat(® )as a tool to stratify breast cancer patients at risk of recurrence during endocrine therapy

por Bartlett, John MS, Thomas, Jeremy, Ross, Douglas T, Seitz, Robert S, Ring, Brian Z, Beck, Rodney A, Pedersen, Hans Christian, Munro, Alison, Kunkler, Ian H, Campbell, Fiona M, Jack, Wilma, Kerr, Gillian R, Johnstone, Laura, Cameron, David A, Chetty, Udi
Publicado 2010

OPTIMA prelim: a randomised feasibility study of personalised care in the treatment of women with early breast cancer.

por Stein, Robert C, Dunn, Janet A, Bartlett, John Ms, Campbell, Amy F, Marshall, Andrea, Hall, Peter, Rooshenas, Leila, Morgan, Adrienne, Poole, Christopher, Pinder, Sarah E, Cameron, David A, Stallard, Nigel, Donovan, Jenny L, McCabe, Christopher, Hughes-Davies, Luke, Makris, Andreas
Publicado en Health Technol Assess (2016)

Nottingham Prognostic Index Plus: Validation of a clinical decision making tool in breast cancer in an independent series

por Green, Andrew R, Soria, Daniele, Stephen, Jacqueline, Powe, Desmond G, Nolan, Christopher C, Kunkler, Ian, Thomas, Jeremy, Kerr, Gillian R, Jack, Wilma, Cameron, David, Piper, Tammy, Ball, Graham R, Garibaldi, Jonathan M, Rakha, Emad A, Bartlett, John MS, Ellis, Ian O
Publicado en J Pathol Clin Res (2016)

Pancreatic cancer ascites xenograft–an expeditious model mirroring advanced therapeutic resistant disease

por Golan, Talia, Stossel, Chani, Schvimer, Michael, Atias, Dikla, Halperin, Sharon, Buzhor, Ella, Raitses-Gurevich, Maria, Cohen, Keren, Pri-Chen, Sara, Wilson, Julie, Denroche, Robert E., Lungu, Ilinca, Bartlett, John M.S., Mbabaali, Faridah, Yarden, Yosef, Nataraj, Nishanth Belugali, Gallinger, Steven, Berger, Raanan
Publicado en Oncotarget (2017)

Sequential docetaxel as adjuvant chemotherapy for early breast cancer (TACT): an open-label, phase III, randomised controlled trial

por Ellis, Paul, Barrett-Lee, Peter, Johnson, Lindsay, Cameron, David, Wardley, Andrew, O'Reilly, Susan, Verrill, Mark, Smith, Ian, Yarnold, John, Coleman, Robert, Earl, Helena, Canney, Peter, Twelves, Chris, Poole, Christopher, Bloomfield, David, Hopwood, Penelope, Johnston, Stephen, Dowsett, Mitchell, Bartlett, John MS, Ellis, Ian, Peckitt, Clare, Hall, Emma, Bliss, Judith M
Publicado 2009

Estrogen Receptor and Progesterone Receptor As Predictive Biomarkers of Response to Endocrine Therapy: A Prospectively Powered Pathology Study in the Tamoxifen and Exemestane Adjuv...

por Bartlett, John M.S., Brookes, Cassandra L., Robson, Tammy, van de Velde, Cornelis J.H., Billingham, Lucinda J., Campbell, Fiona M., Grant, Margaret, Hasenburg, Annette, Hille, Elysée T.M., Kay, Charlene, Kieback, Dirk G., Putter, Hein, Markopoulos, Christos, Kranenbarg, Elma Meershoek-Klein, Mallon, Elizabeth A., Dirix, Luc, Seynaeve, Caroline, Rea, Daniel
Publicado 2011

An International Ki67 Reproducibility Study

por Polley, Mei-Yin C., Leung, Samuel C. Y., McShane, Lisa M., Gao, Dongxia, Hugh, Judith C., Mastropasqua, Mauro G., Viale, Giuseppe, Zabaglo, Lila A., Penault-Llorca, Frédérique, Bartlett, John M.S., Gown, Allen M., Symmans, W. Fraser, Piper, Tammy, Mehl, Erika, Enos, Rebecca A., Hayes, Daniel F., Dowsett, Mitch, Nielsen, Torsten O.
Publicado 2013

Recommendations for Human Epidermal Growth Factor Receptor 2 Testing in Breast Cancer: American Society of Clinical Oncology/College of American Pathologists Clinical Practice Guid...

por Wolff, Antonio C., Hammond, M. Elizabeth H., Hicks, David G., Dowsett, Mitch, McShane, Lisa M., Allison, Kimberly H., Allred, Donald C., Bartlett, John M.S., Bilous, Michael, Fitzgibbons, Patrick, Hanna, Wedad, Jenkins, Robert B., Mangu, Pamela B., Paik, Soonmyung, Perez, Edith A., Press, Michael F., Spears, Patricia A., Vance, Gail H., Viale, Giuseppe, Hayes, Daniel F.
Publicado 2013